Articles

1. Revisiting the use of the EORTC QLQ-STO22 to assess health-related quality of life of patients with gastric cancer: incorporating updated treatment options and cross-cultural perspectives

   • S. C. Sodergren
   • A. Hurley-Wallace
   • On behalf of the EORTC Quality of Life Group

   Original Article Open access 26 April 2024

2. Identification of maximal tumor size associated with negligible lymph node metastasis for endoscopic submucosal dissection of undifferentiated-type early gastric cancer

   • Sung Eun Oh
   • Soomin Ahn
   • Ji Yeong An

   Original Article 25 April 2024

   

3. Discordant PD-L1 results between 28–8 and 22C3 assays are associated with outcomes of gastric cancer patients treated with nivolumab plus chemotherapy

   • Hyung-Don Kim
   • Jinho Shin
   • Young Soo Park

   Original Article 22 April 2024

   

4. Family history and gastric cancer incidence and mortality in Asia: a pooled analysis of more than half a million participants

   • Dan Huang
   • Minkyo Song
   • Daehee Kang

   Original Article Open access 22 April 2024

5. Feasibility of intraoperative pathologic examination for sentinel lymph nodes during sentinel node navigation surgery in early gastric cancer: results of pathologic protocol for SENORITA trial

   • Sin Hye Park
   • Soo Young Chung
   • Myeong-Cherl Kook

   Original Article 22 April 2024

   

6. International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape

   • Paolo Morgagni
   • Maria Bencivenga
   • Giovanni de Manzoni

   Original Article Open access 18 April 2024

   

7. Adding salt to food at table as an indicator of gastric cancer risk among adults: a prospective study

   • Selma Kronsteiner-Gicevic
   • Alysha S. Thompson
   • Tilman Kühn

   Original Article Open access 17 April 2024

   

8. Letter to the editor: 5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer

   • Hyung-Don Kim
   • Min-Hee Ryu
   • Yoon-Koo Kang

   Letter to the Editor 11 April 2024

9. Genome-wide 5-hydroxymethylcytosines in circulating cell-free DNA as noninvasive diagnostic markers for gastric cancer

   • Yingli Fu
   • Jing Jiang
   • Xueyuan Cao

   Original Article 07 April 2024

   

10. Precise highlighting of the pancreas by semantic segmentation during robot-assisted gastrectomy: visual assistance with artificial intelligence for surgeons

    • Tatsuro Nakamura
    • Nao Kobayashi
    • Hisashi Shinohara

    Original Article 04 April 2024

    

11. Global burden of young-onset gastric cancer: a systematic trend analysis of the global burden of disease study 2019

    • Yunhao Li
    • Anne I. Hahn
    • Wai K. Leung

    Original Article Open access 03 April 2024

    

12. Risk prediction model for gastric cancer within 5 years in healthy Korean adults

    • Hyungseok Oh
    • Sunwoo Cho
    • Yoosoo Chang

    Original Article 01 April 2024

    

13. Prognostic value of mismatch repair deficiency in patients receiving first-line fluoropyrimidine plus platinum for metastatic, recurrent, or unresectable gastric cancer

    • Chung Ryul Oh
    • Eo Jin Kim
    • Yoon-Koo Kang

    Original Article 31 March 2024

    

14. Correction: Ubiquitous mitochondrial creatine kinase promotes the progression of gastric cancer through a JNK-MAPK/JUN/HK2 axis regulated glycolysis

    • Yushuai Mi
    • Quanhui Li
    • Yinlu Ding

    Correction Open access 22 March 2024 Pages: 646 - 648

    

15. Correction: Resistance to FGFR1-targeted therapy leads to autophagy via TAK1/AMPK activation in gastric cancer

    • Rui Peng
    • Yan Chen
    • Yun Chen

    Correction 21 March 2024 Pages: 643 - 645

    

16. Superior lymph node harvest by fluorescent lymphography during minimally invasive gastrectomy for gastric cancer patients with high body mass index

    • Ki-Yoon Kim
    • Jawon Hwang
    • Woo Jin Hyung

    Original Article 19 March 2024 Pages: 622 - 634

    

17. Ethnic‑specific associations between body mass index and gastric cancer: a Mendelian randomization study in European and Korean populations

    • Zhe Wang
    • Da Li
    • Cheng Zhang

    Letter to the Editor 18 March 2024 Pages: 641 - 642

18. Adjuvant treatment for locally advanced gastric cancer: an Asian perspective

    • Hyung-Don Kim
    • Min-Hee Ryu
    • Yoon-Koo Kang

    Review Article 15 March 2024 Pages: 439 - 450

    

19. Specific lineage transition of tumor-associated macrophages elicits immune evasion of ascitic tumor cells in gastric cancer with peritoneal metastasis

    • Yilin Li
    • Lei Jiang
    • Lin Shen

    Original Article Open access 09 March 2024 Pages: 519 - 538

    

20. Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for the treatment of locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): an open-label, randomized, phase 2 clinical trial

    • Zhichao Jiang
    • Yibin Xie
    • Aiping Zhou

    Original Article Open access 08 March 2024 Pages: 571 - 579

    

21. Clinicopathological significance of microsatellite instability and immune escape mechanism in patients with gastric solid-type poorly differentiated adenocarcinoma

    • Shinya Umekita
    • Daisuke Kiyozawa
    • Yoshinao Oda

    Original Article 05 March 2024 Pages: 484 - 494

    

22. Patient metabolic profile defined by liver and muscle ¹⁸F-FDG PET avidity is independently associated with overall survival in gastric cancer

    • Gerardo A. Vitiello
    • Vetri Sudar Jayaprakasam
    • Vivian E. Strong

    Original Article 04 March 2024 Pages: 548 - 557

    

23. Dietary intake of vitamin C and gastric cancer: a pooled analysis within the Stomach cancer Pooling (StoP) Project

    • Michele Sassano
    • Monireh Sadat Seyyedsalehi
    • Paolo Boffetta

    Original Article Open access 04 March 2024 Pages: 461 - 472

    

24. Racial disparities of gastric cancer in the USA: an overview of epidemiology, global screening guidelines, and targeted screening in a heterogeneous population

    • Jean Woo Mok
    • Yeong Ha Oh
    • Sekhar Padmanabhan

    Review Article 04 March 2024 Pages: 426 - 438

25. Statin use in relation to long-term survival after gastrectomy for gastric adenocarcinoma: a Swedish population-based cohort study

    • Dag Holmberg
    • Joonas H. Kauppila
    • Jesper Lagergren

    Original Article Open access 02 March 2024 Pages: 590 - 597

    

26. Discrepant effect of high-density lipoprotein cholesterol on esophageal and gastric cancer risk in a nationwide cohort

    • Su Youn Nam
    • Junwoo Jo
    • Seong Woo Jeon

    Original Article 28 February 2024 Pages: 451 - 460

    

27. Gastric fundic gland polyposis and cancer development after eradication of Helicobacter pylori in patient with gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS)

    • Koichi Okamoto
    • Tomoyuki Kawaguchi
    • Tetsuji Takayama

    Case Report 26 February 2024 Pages: 635 - 640

    

28. Impact of preoperative prealbumin levels on long-term prognosis in patients with gastric cancer after gastrectomy: a retrospective cohort study

    • Ryota Matsui
    • Satoshi Ida
    • Souya Nunobe

    Original Article 24 February 2024 Pages: 611 - 621

    

29. Killer cell lectin-like receptor G2 facilitates aggressive phenotypes of gastric cancer cells via dual activation of the ERK1/2 and JAK/STAT pathways

    • Yuki Ito
    • Mitsuro Kanda
    • Yasuhiro Kodera

    Original Article 22 February 2024 Pages: 506 - 518

    

30. Elucidating molecular mechanisms and therapeutic synergy: irreversible HER2-TKI plus T-Dxd for enhanced anti-HER2 treatment of gastric cancer

    • Jiankun Liu
    • Tienian Zhu
    • Jingpu Liu

    Original Article Open access 22 February 2024 Pages: 495 - 505

    

31. Clinical practice guidelines for esophagogastric junction cancer: Upper GI Oncology Summit 2023

    • Yuko Kitagawa
    • Satoru Matsuda
    • Takeshi Sano

    Special Article Open access 22 February 2024 Pages: 401 - 425

32. Long-term oncological outcomes of 3D versus 2D laparoscopic gastrectomy for gastric cancer: a randomized clinical trial

    • Qing Zhong
    • Jun-Yu Chen
    • Chao-Hui Zheng

    Original Article 20 February 2024 Pages: 598 - 610

    

33. Nishi memorial award in gastric cancer

    Announcement 14 February 2024 Pages: 400 - 400

    

34. Sustained exposure to Helicobacter pylori induces immune tolerance by desensitizing TLR6

    • Xiulin Zhang
    • Yang He
    • Changlong Li

    Original Article Open access 04 February 2024 Pages: 324 - 342

    

35. Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial

    • Zev A. Wainberg
    • Yoon-Koo Kang
    • Peter C. Enzinger

    Original Article Open access 03 February 2024 Pages: 558 - 570

    

36. Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial

    • Yoon-Koo Kang
    • Min-Hee Ryu
    • Narikazu Boku

    Original Article Open access 28 January 2024 Pages: 375 - 386

    

37. Inhibition of proprotein convertases activity results in repressed stemness and invasiveness of cancer stem cells in gastric cancer

    • Anissa Zaafour
    • Lornella Seeneevassen
    • Christine Varon

    Original Article 27 January 2024 Pages: 292 - 307

    

38. Chromosomal copy number amplification-driven Linc01711 contributes to gastric cancer progression through histone modification-mediated reprogramming of cholesterol metabolism

    • Ben Yue
    • Jianjun Chen
    • Chunchao Zhu

    Original Article 25 January 2024 Pages: 308 - 323

    

39. Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer models

    • Elisabetta Puliga
    • Chiara De Bellis
    • Silvia Giordano

    Original Article Open access 23 January 2024 Pages: 473 - 483

    

40. N⁶-methyladenosine-modified MIB1 promotes stemness properties and peritoneal metastasis of gastric cancer cells by ubiquitinating DDX3X

    • Peng Xu
    • Kanghui Liu
    • Diancai Zhang

    Original Article 22 January 2024 Pages: 275 - 291

    

41. Early endpoints of a randomized phase II trial of preoperative chemotherapy with S-1/CDDP with or without trastuzumab followed by surgery for HER2-positive resectable gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301C (Trigger Study)

    • Masanori Tokunaga
    • Nozomu Machida
    • Masanori Terashima

    Original Article 19 January 2024 Pages: 580 - 589

    

42. Diagnostic performance of deep-learning-based virtual chromoendoscopy in gastric neoplasms

    • Sho Suzuki
    • Yusuke Monno
    • Masatoshi Okutomi

    Original Article 19 January 2024 Pages: 539 - 547

    

43. Dose–response association between cigarette smoking and gastric cancer risk: a systematic review and meta-analysis

    • Matteo Rota
    • Irene Possenti
    • Alessandra Lugo

    Review Article 17 January 2024 Pages: 197 - 209

    

44. CEACAM5 and TROP2 define metaplastic and dysplastic transitions in human antral gastric precancerous lesions and tumors

    • Bogun Jang
    • Su-Hyung Lee
    • James R. Goldenring

    Original Article 14 January 2024 Pages: 263 - 274

    

45. Tumor-infiltrating monocytic myeloid-derived suppressor cells contribute to the development of an immunosuppressive tumor microenvironment in gastric cancer

    • Chikanori Tsutsumi
    • Kenoki Ohuchida
    • Masafumi Nakamura

    Original Article 13 January 2024 Pages: 248 - 262

    

46. Sex-dependent different clinicopathological characterization of Epstein–Barr virus-associated gastric carcinoma: a large-scale study

    • Ji-Hyun Kim
    • Nayoung Kim
    • Soyeon Ahn

    Original Article Open access 11 January 2024 Pages: 221 - 234

    

47. Short-term outcomes of preoperative chemotherapy with docetaxel, oxaliplatin, and S-1 for gastric cancer with extensive lymph node metastasis (JCOG1704)

    • Yukinori Kurokawa
    • Yuichiro Doki
    • Masanori Terashima

    Original Article Open access 05 January 2024 Pages: 366 - 374

    

48. The impact of contour maps on estimating the risk of gastrointestinal stromal tumor recurrence: indications for adjuvant therapy: an analysis of the Kinki GIST registry

    • Ryugo Teranishi
    • Tsuyoshi Takahashi
    • Toshimasa Tsujinaka

    Original Article Open access 25 December 2023 Pages: 355 - 365

    

49. Oncological outcomes of conversion therapy in gastric cancer patients with peritoneal metastasis: a large-scale retrospective cohort study

    • Zhongyin Yang
    • Sheng Lu
    • Zhenggang Zhu

    Original Article Open access 24 December 2023 Pages: 387 - 399

    

50. FBXW7 regulates the sensitivity of imatinib in gastrointestinal stromal tumors by targeting MCL1

    • Xiyu Wu
    • Masaaki Iwatsuki
    • Hideo Baba

    Original Article 24 December 2023 Pages: 235 - 247